Pulmonx Corp (LUNG) financials
Pulmonx revenue and earnings by year
Pulmonx's revenue was $90.5 million in the fiscal year to December 31, 2025, up 8.0% from the year before. Net income was -$54.0 million, -59.7% of revenue. Since the fiscal year to December 31, 2018, revenue has grown 24.1% a year on average.
Fiscal years, each labelled by the calendar year it ended in.
Income statement, the last 8 fiscal years
| Fiscal year to | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 90 | 84 | 69 | 54 | 48 | 33 | 33 | 20 |
| Revenue growth | 8.0% | 22.0% | 28.0% | 10.8% | 47.9% | 0.4% | 62.9% | — |
| Gross profit | 67 | 62 | 51 | 40 | 36 | 21 | 22 | 12 |
| Gross margin | 74.2% | 74.0% | 73.9% | 74.3% | 73.6% | 64.8% | 68.8% | 61.4% |
| Operating income | -54 | -58 | -62 | -59 | -47 | -32 | -18 | -15 |
| Operating margin | -59.3% | -68.9% | -90.2% | -109.3% | -97.7% | -98.8% | -54.7% | -75.2% |
| Net income | -54 | -56 | -61 | -59 | -49 | -32 | -21 | -18 |
| Net margin | -59.7% | -67.3% | -88.6% | -109.8% | -100.5% | -98.5% | -63.5% | -92.4% |
| Diluted EPS | -$1.33 | -$1.44 | -$1.60 | -$1.59 | -$1.35 | -$3.16 | — | — |
| Free cash flow | -33 | -33 | -38 | -46 | -45 | -32 | -21 | -19 |
Diluted EPS is stated in today's shares (adjusted for every split since). Quarterly statements and the income statement as a flow chart are in the app: open LUNG in Markets.
See also: LUNG returns
No forecast, no recommendation. This page describes Pulmonx Corp from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.